Tuberculosis and addictions: a deadly trio?

#Tuberculosis #Addiction #Immunity #Alcohol #Smoking #Drugs    


Tuberculosis (TB), an infection caused by Mycobacterium tuberculosis, remains one of the world’s deadliest infectious diseases. In 2023, it affected more than 10 million people and caused approximately 1.25 million deaths, particularly in low- and middle-income countries. Despite the availability of effective and well-established treatments, therapeutic failure and treatment abandonment rates remain alarmingly high. While treatment failure is often attributed to bacterial resistance or limited access to care, behavioral factors are frequently underestimated contributors. Excessive alcohol consumption, smoking, and drug use play a crucial yet under-addressed role in TB management strategies.  

These lifestyle habits are associated with both biological and social harms. From a pathophysiological perspective, they impair both innate and adaptive immunity, undermine treatment responses, and facilitate disease progression. Behaviorally, they contribute to poor adherence, delays in diagnosis, social instability, and reduced engagement in long-term care. Nevertheless, these factors remain insufficiently evaluated in most clinical approaches and public health policies.  

In this context, the present study was initiated to precisely assess the impact of risk behaviors on the effectiveness of tuberculosis treatment, with the goal of informing clinical practices and health strategies.    

Is treatment failure programmed by addiction?

This study is based on a large sample of 180,119 tuberculosis patients from 19 observational studies, primarily conducted in low- and middle-income countries. The participants, from diverse backgrounds, included adult men and women with pulmonary or extrapulmonary forms of TB, with or without HIV co-infection, and often in situations of severe social vulnerability. Three risk behaviors were assessed: alcohol consumption, smoking, and psychoactive substance use, measured through questionnaires, interviews, or medical records.  

The findings highlight a statistically significant association between alcohol consumption, smoking, illicit drug use, and tuberculosis treatment failure. More specifically, alcohol consumption nearly doubles the risk of treatment failure. Tobacco use and drug abuse also significantly increase this risk. Sensitivity analyses confirmed the robustness of these results, showing moderate to low heterogeneity and no evidence of publication bias. On the physiological level, the mechanisms involved include impaired innate immunity, particularly macrophage dysfunction and disruption of mucociliary clearance. Reduced treatment adherence was also observed, leading to prolonged treatment duration, the development of drug-resistant forms, and an overall worse prognosis.    

Treating tuberculosis also means addressing lifestyles  

Tuberculosis remains a global public health challenge, largely due to multiple factors that compromise treatment success. Among these, modifiable risk behaviors—such as alcohol use, smoking, and drug abuse—not only impair immune response but also reduce treatment adherence.  

This study aimed to quantify the precise impact of these behaviors on TB treatment outcomes in order to better guide clinical and public health strategies. The results show a clear link between these behaviors and an increased risk of treatment failure, highlighting the need to systematically screen for and address them in TB management.  

However, certain limitations must be taken into account, which justify further research. Future directions include the development of targeted interventions, such as cessation programs, enhanced psychological support, and the systematic integration of behavioral risk factors into clinical protocols. Sustainable TB control requires a comprehensive approach that combines biomedical efficacy with attention to behavioral determinants. 

Read next: MDR-TB: 9 months to change everything?